Medical Technology

With an aging population, the demand for healthcare in general and medical device technologies in particular continues to grow. Companies developing innovative medical device technologies serving large unmet clinical needs offer compelling investment returns. Their patent-protected products can achieve rapid revenue growth and attractive gross margins over extended periods of time.

The medical device industry is a fast changing landscape which provides an abundance of opportunities for knowledgeable investors. Innovation in medical technology continues to accelerate as companies develop smaller, less invasive and more cost-effective diagnostics and therapies. In addition, drug-device combinations are being developed to enhance the therapeutic efficacy of core device technologies. Young entrepreneurial companies are also finding novel ways to apply existing technologies to new clinical indications throughout the body.

Our focus across the spectrum of investment stages allows SightLine to find value regardless of overall market conditions. We seek companies with unique and proprietary technologies that meet the following criteria:

• Large unmet clinical need
• Win/Win therapies - patients, physicians and payers do better
• Reasonable development, clinical, regulatory and reimbursement timelines
• Strong, experienced management team in place or readily recruitable
• Use fits into established practice patterns
• Highly defensible patent and market position

We believe that some therapeutic areas are more attractive than others from an investment standpoint. Specifically, we will focus our investing activities on medical technology companies that are developing proprietary medical devices for treating unmet clinical needs in high value therapeutic areas such as vascular diseases, diabetes, spine, stroke prevention and treatment of pulmonary disease.

See our Medical Technology portfolio companies